A patient's own skin cells may one day treat multiple diseases

UC Davis investigator provides roadmap to overcome obstacles for using induced pluripotent stem cells

2011-08-06

(Press-News.org) (SACRAMENTO, Calif.) — The possibility of developing stem cells from a patient's own skin and using them to treat conditions as diverse as Parkinson's disease, Alzheimer's disease and cancer has generated tremendous excitement in the stem cell research community in recent years. Such therapies would avoid the controversial need for using stem cells derived from human embryos, and in theory, also bypass immunological problems inherent in using cells from one person to treat another.

However, in the nearly five years since the first article describing the development of stem cells derived from adult cells — so-called induced pluripotent stem cells (iPSCs) — unique problems inherent in their use have surfaced and even their immunological safety has been called into question.

According to Paul S. Knoepfler, UC Davis associate professor of cell biology and human anatomy, finding such obstacles in such a new and novel approach is not surprising and should not dissuade investigators from actively pursuing this avenue of research. A roadmap for finding solutions to the problems identified with iPSCs, written by Knoepfler and Bonnie Barrilleaux, a postdoctoral fellow working in Knoepfler's laboratory, is available online and will be published in the Aug. 5 issue of the journal Cell Stem Cell. Their perspective, "Inducing iPSCs to escape the dish," suggests research strategies to advance the field more rapidly toward applications for human diseases.

"iPSCs offer the potential to treat many diseases as an alternative or adjuvant therapy to drugs or surgery," said Knoepfler, who also is a faculty member of the UC Davis Genome Center and UC Davis Cancer Center. "Problems that have been identified with their use likely can be overcome, allowing iPSCs to jump from the laboratory dish to patients who could benefit from them."

iPSCs were first produced in 2006 from mouse cells and in 2007 from human cells. They have many of the same regenerative properties as human embryonic stem cells, but they are derived in a lab from adult cells, such as skin cells, by inducing or forcing them to express specific genes that are normally dormant in that type of cell. In theory, a person's skin cells could be induced to make neurons that produce the neurotransmitter dopamine, for example, and be delivered to brain regions where it is lacking in patients with Parkinson's disease. Similarly, cells could be induced to regenerate heart muscle and blood vessels after a heart attack, or neurons following a spinal cord injury. Many labs at UC Davis, including the Knoepfler lab, are producing and studying human iPSCs.

One advantage cited for iPSCs over stem cells derived from embryos is that problems of rejection due to immunological differences between the donor (the embryo) and the patient would be eliminated, because the iPSCs would be derived from each individual patient. A recent study using iPSCs in mice found that tissue rejection may, in fact, occur in some cases. However, Knoepfler believes that particular study was conducted in the context of tumors, which tend to be highly immunogenic and not be applicable for human use. While the ability of human iPSCs to escape immune attention must be investigated further, Knoepfler says that iPSCs remain an attractive potential avenue for stem cell-based medicine, in addition to embryonic stem cells.

Another concern with using either iPSCs or embryonic stem cells is that cells with the ability to turn into many different cell types may grow out of control, producing cancerous tumors. Knoepfler points out those studies involved implanting large numbers of undifferentiated stem cells into mice that were treated with immunosuppressant drugs to reject transplants, making the conditions ideal for cancers to arise. This scenario, he argues, is unlikely to be applicable when treating humans for actual diseases. In such cases, the stem cells would be induced to have a specific function, and the body's natural immune defenses would be present.

The "pluripotent" nature of stem cells, which potentially allow their use to repair almost any tissue, is only beginning to be harnessed for human therapies. Stem cell therapy has already been successfully used for years to treat leukemia and related bone and blood cancers. The use of iPSCs could vastly increase the spectrum of diseases that might be treated with stem cells, without the safety and ethical concerns inherent in using embryonic stem cells.

"Dr. Barrilleaux and I argue for a shift in research priorities," said Knoepfler. "Future studies of iPSCs should increasingly focus on issues most relevant to the eventual clinical use of the cells, offering the fastest pathway to treating patients with this potentially powerful therapeutic tool."

Knoepfler's own research focuses on determining how stem cell behavior is controlled during normal embryonic development as well as during healing and regeneration. He also studies how control systems go awry in developmental disorders and cancer. One key direction for the Knoepfler lab is using leading genomics technology to better understand why stem cells behave the way they do and how to change that behavior for clinical use.

### Funding for Knoepfler's article was provided by a grant from the California Institute for Regenerative Medicine.

ABOUT UC DAVIS STEM CELL RESEARCH UC Davis has brought together physicians, research scientists, biomedical engineers and a range of other experts and collaborative partners to establish the UC Davis Institute for Regenerative Cures, a facility supported by the California Institute for Regenerative Medicine. The $62 million institute is housed on the university's Sacramento campus, where collaborative, team-oriented science is advancing breakthrough discoveries and working to bring stem cell therapies and cures to patients. For more information, visit www.ucdmc.ucdavis.edu/stemcellresearch/

ELSE PRESS RELEASES FROM THIS DATE:

US physician practices spend 4 times Canadian practices

2011-08-06

NEW YORK (Aug. 4, 2011) -- Physicians in the United States spend nearly four times as much dealing with health insurers and payers compared with doctors in Canada. Most of the difference stems from the fact that Canadian physicians deal with a single payer, in contrast to the multiple payers in the United States. These findings are published in the August issue of the journal Health Affairs -- the result of a research collaboration among Weill Cornell Medical College, Cornell University–Ithaca, the University of Toronto, and the Medical Group Management Association. Administrative ...

Wireless network in hospital monitors vital signs

2011-08-06

A clinical warning system that uses wireless sensors to track the vital signs of at-risk patients is undergoing a feasibility study at Barnes-Jewish Hospital in St. Louis. When the full system is operational sensors will take blood oxygenation and heart-rate readings from at-risk patients once or twice a minute. The data will be transmitted to a base station, where they will be combined with other data in the patient's electronic medical record, such as lab test results. The incoming vital signs and data in the medical record will be continually scrutinized by a machine-learning ...

U of Minnesota researchers discover a natural food preservative that kills food-borne bacteria

2011-08-06

University of Minnesota researchers have discovered and received a patent for a naturally occurring lantibiotic — a peptide produced by a harmless bacteria — that could be added to food to kill harmful bacteria like salmonella, E. coli and listeria. The U of M lantibiotic is the first natural preservative found to kill gram-negative bacteria, typically the harmful kind. "It's aimed at protecting foods from a broad range of bugs that cause disease," said Dan O'Sullivan, a professor of food science and nutrition in the university's College of Food, Agricultural and Natural ...

Females can place limits on evolution of attractive features in males, research shows

2011-08-06

AUDIO: Male túngara frogs producing their distinctive "whine " and "chuck " calls to attract females. Click here for more information. AUSTIN, Texas—Female cognitive ability can limit how melodious or handsome males become over evolutionary time, biologists from The University of Texas at Austin, Louisiana State University Health Sciences Center and the Smithsonian Tropical Research Institute have observed. Males across the animal world have evolved ...

University of Virginia researchers uncover new catalysis site

2011-08-06

Mention catalyst and most people will think of the catalytic converter, an emissions control device in the exhaust system of automobiles that reduces pollution. But catalysts are used for a broad variety of purposes, including the conversion of petroleum and renewable resources into fuel, as well as the production of plastics, fertilizers, paints, solvents, pharmaceuticals and more. About 20 percent of the gross domestic product in the United States depends upon catalysts to facilitate the chemical reactions needed to create products for everyday life. Catalysts are ...

Potential new eye tumor treatment discovered

2011-08-06

Baltimore, MD — New research from a team including several Carnegie scientists demonstrates that a specific small segment of RNA could play a key role in the growth of a type of malignant childhood eye tumor called retinoblastoma. The tumor is associated with mutations of a protein called Rb, or retinoblastoma protein. Dysfunctional Rb is also involved with other types of cancers, including lung, brain, breast and bone. Their work, which will be the cover story of the August 15th issue of Genes & Development, could result in a new therapeutic target for treating this rare ...

Targeting innate immunity in malaria

2011-08-06

WORCESTER, Mass. – Scientists at the University of Massachusetts Medical School have uncovered a novel DNA-sensing pathway important to the triggering of an innate immune response for malaria. Activation of this pathway appears to stimulate production of an overabundance of type-1 interferon by the immune system that may contribute to inflammation and fever in malaria patients and could play a part in susceptibility for the most common and lethal form of malaria known as plasmodium falciparum. Published online by Immunity this week, the study offers the first evidence that ...

Questions to Ask Your Plastic Surgeon Before Breast Augmentation

2011-08-06

The decision to have breast augmentation surgery is an important one that involves multiple factors. Breast augmentation has the ability to improve your self-esteem, increase self-confidence and feelings of appeal, and even improve your clothing options. It also has physical and aesthetic risks which should be fully considered prior to undergoing the procedure. Breast augmentation is the most popular form of plastic surgery in the United States, with more than 250,000 performed every year. This does not mean that the procedure is right for you and, like any elective ...

New Montana State research sheds light on South Pole dinosaurs

2011-08-06

BOZEMAN, Mont. – Dog-sized dinosaurs that lived near the South Pole, sometimes in the dark for months at a time, had bone tissue very similar to dinosaurs that lived everywhere on the planet, according to a doctoral candidate at Montana State University. That surprising fact falsifies a 13-year-old study and may help explain why dinosaurs were able to dominate the planet for 160 million years, said Holly Woodward, MSU graduate student in the Department of Earth Sciences and co-author of a paper published Aug. 3 in the journal "PLoS ONE." "If we were trying to find evidence ...

Rice discovery points way to graphene circuits

2011-08-06

HOUSTON -- (Aug. 4, 2011) -- Rice University materials scientists have made a fundamental discovery that could make it easier for engineers to build electronic circuits out of the much-touted nanomaterial graphene. Graphene's stock shot sky-high last year when the nanomaterial attracted the Nobel Prize in physics. Graphene is a layer of carbon atoms that is just one atom thick. When stacked atop one another, graphene sheets form graphite, the material found in pencils the world over. Thanks to the tools of nanotechnology, scientists today can make, manipulate and study ...

A patient's own skin cells may one day treat multiple diseases

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: